首页> 外文期刊>Experimental and clinical transplantation >Pulmonary Involvement in Brucellosis, a Rare Complication of Renal Transplant: Case Report and Brief Review
【24h】

Pulmonary Involvement in Brucellosis, a Rare Complication of Renal Transplant: Case Report and Brief Review

机译:布鲁氏菌病(一种罕见的肾脏移植并发症)中的肺部介入:病例报告和简要回顾

获取原文
           

摘要

Brucellosis, a disease endemic in many countries including Turkey, is a systemic infectious disease. Brucellosis is rare in renal transplant recipients. Only 4 cases have been reported in the literature. In this report, we describe the clinical manifestations and laboratory findings of a brucellosis case with pulmonary involvement in a renal transplant recipient. A 20-year-old man who had a living-donor kidney transplant 4 months earlier presented to our transplant clinic with fever, cough, and right flank pain. Clarithromycin and ceftriaxone were started for the diagnosis of pneumonia. However, piperacillin/tazobactam, mero?-penem plus teicoplanin, and antituberculosis treatment were continued because the patient was unresponsive to the initial therapy. Serum Brucella agglutination titer was found to be 1/320. Treatment was started with a 6-week course of oral doxycycline and rifampin, resulting in cure. Brucellosis and especially its pulmonary involvement are rare after kidney transplant. However, in endemic areas, it should be considered as it mimics several other infectious diseases.
机译:布鲁氏菌病是许多国家(包括土耳其)的特有疾病,是一种系统性传染病。布鲁氏菌病在肾移植患者中很少见。文献中仅报道了4例。在本报告中,我们描述了在肾脏移植接受者中发生肺部感染的布鲁氏菌病病例的临床表现和实验室检查结果。一名4个月前进行了活体供肾移植的20岁男子因发烧,咳嗽和右胁疼痛出现在我们的移植诊所。开始使用克拉霉素和头孢曲松钠诊断肺炎。但是,哌拉西林/他唑巴坦,甲吗啡-青霉烯加替考拉宁和抗结核治疗继续进行,因为该患者对初始治疗无反应。发现血清布鲁氏菌凝集滴度为1/320。治疗开始于口服强力霉素和利福平6周疗程,从而治愈。肾移植后,布鲁氏菌病,尤其是其肺部受累很少见。但是,在流行地区,由于它模仿了其他几种传染病,因此应予以考虑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号